Incysus Therapeutics Inc. announced that Joy E. Bessenger has been appointed senior vice president, finance and strategy. She has more than 25 years of experience in finance and biotechnology. She most recently served as chief financial officer at 3D Forensic. Prior to 3D Forensic, she was the Vice President of Strategy and Development at deCODE Genetics.